2025 China Drug Catalog Boosts Access with 114 ...

By HEOR Staff Writer

December 9, 2025

Expansion of Coverage in the 2025 National Basic Medical Insurance Drug Catalog In this update we highlight updates and implications of the 2025 Nationa...
NICE Approves Seven Digital Cardiac Rehabilitation Technologies for Enhanced ...
Advancing EU Health Technology Assessment: Key Priorities in the HTACG Draft ...
WHO Guidelines Set New Standard for GLP-1 Obesity Therapies in Adults
Strengthening EU Pharmaceutical Supply Security Through the Critical Medicine...
Biomanufacturing Excellence Act: Strengthening U.S. Biopharmaceutical Manufac...
Medicare Drug Price Negotiations: Major Savings for Seniors on Cancer and Chr...
Enhancing Efficiency in FAST-EU Clinical Trials: A New Era for Biomedical Res...
Advancements in Continuous Glucose Monitoring for Type 2 Diabetes Management
Accelerating Access to Latin America Innovative Therapies Through Collaborati...
Rethinking HEOR Market Access Integration: A Call for Early Engagement Before...
Patient-Reported Outcomes Trends in Clinical Trials: Insights from 2008-2023
Health Investment Returns: Harnessing Health as a Strategic Economic Asset